TABLE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USDMILLION 2014–2023 36
TABLE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY (SCIT) USDMILLION 2014–2023 37
TABLE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY USDMILLION 2014–2023 38
TABLE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPES OF ALLERGIES USD MILLION 2014–2023 39
TABLE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR RHINITIS USD MILLION 2014–2023 40
TABLE 6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA USD MILLION 2014–2023 40
TABLE 7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR EYE ALLERGY USD MILLION 2014–2023 41
TABLE 8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SKIN ALLERGY USD MILLION 2014–2023 41
TABLE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 42
TABLE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITALS USD MILLION 2014–2023 43
TABLE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR CLINICS USD MILLION 2014–2023 43
TABLE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR DIAGNOSTIC CENTERS USD MILLION 2014–2023 44
TABLE 13 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 45
TABLE 14 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 46
TABLE 15 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 47
TABLE 16 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 47
TABLE 17 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 48
TABLE 18 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 48
TABLE 19 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 49
TABLE 20 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 50
TABLE 21 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 50
TABLE 22 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 51
TABLE 23 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 51
TABLE 24 US ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 53
TABLE 25 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 53
TABLE 26 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 54
TABLE 27 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 54
TABLE 28 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 55
TABLE 29 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 56
TABLE 30 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 56
TABLE 31 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 57
TABLE 32 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 57
TABLE 33 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 58
TABLE 34 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 58
TABLE 35 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 59
TABLE 36 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 59
TABLE 37 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 61
TABLE 38 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 61
TABLE 39 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 62
TABLE 40 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 62
TABLE 41 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 63
TABLE 42 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 63
TABLE 43 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 64
TABLE 44 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 64
TABLE 45 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 65
TABLE 46 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 65
TABLE 47 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 66
TABLE 48 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 66
TABLE 49 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 67
TABLE 50 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 67
TABLE 51 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 68
TABLE 52 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 69
TABLE 53 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 69
TABLE 54 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 70
TABLE 55 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 70
TABLE 56 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 72
TABLE 57 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 73
TABLE 58 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 73
TABLE 59 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 75
TABLE 60 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 75
TABLE 61 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 76
TABLE 62 PERU ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 76
TABLE 63 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 77
TABLE 64 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 77
TABLE 65 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 78
TABLE 66 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 78
TABLE 67 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 79
TABLE 68 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 79
TABLE 69 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 80
TABLE 70 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 81
TABLE 71 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 81
TABLE 72 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 82
TABLE 73 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 82
TABLE 74 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 83
TABLE 75 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 84
TABLE 76 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 84
TABLE 77 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 85
TABLE 78 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 85
TABLE 79 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 86
TABLE 80 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 86
TABLE 81 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 87
TABLE 82 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 87
TABLE 83 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 88
TABLE 84 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 88
TABLE 85 UK ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 90
TABLE 86 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 90
TABLE 87 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 91
TABLE 88 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 91
TABLE 89 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 92
TABLE 90 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 92
TABLE 91 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 94
TABLE 92 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 94
TABLE 93 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 95
TABLE 94 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 95
TABLE 95 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 96
TABLE 96 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 96
TABLE 97 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 97
TABLE 98 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2014–2023 97
TABLE 99 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 98
TABLE 100 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 99
TABLE 101 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 99
TABLE 102 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 100
TABLE 103 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 100
TABLE 104 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 100
TABLE 105 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 101
TABLE 106 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 102
TABLE 107 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 102
TABLE 108 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2014–2023 103
TABLE 109 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 103
TABLE 110 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 104
TABLE 111 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 104
TABLE 112 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 105
TABLE 113 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 105
TABLE 114 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 107
TABLE 115 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 107
TABLE 116 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 108
TABLE 117 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 108
TABLE 118 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 109
TABLE 119 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 110
TABLE 120 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 110
TABLE 121 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 111
TABLE 122 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 111
TABLE 123 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 112
TABLE 124 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 112
TABLE 125 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 113
TABLE 126 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 113
TABLE 127 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 115
TABLE 128 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 115
TABLE 129 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 116
TABLE 130 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 116
TABLE 131 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 117
TABLE 132 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 117
TABLE 133 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 118
TABLE 134 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 118
TABLE 135 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 119
TABLE 136 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 119
TABLE 137 REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 120
TABLE 138 NEW ZEALAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 120
TABLE 139 NEW ZEALAND PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 121
TABLE 140 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 121
TABLE 141 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 122
TABLE 142 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 123
TABLE 143 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 123
TABLE 144 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 124
TABLE 145 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 124
TABLE 146 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 125
TABLE 147 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 125
TABLE 148 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 126
TABLE 149 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 126
TABLE 150 ALK-ABELLÓ A/S: KEY DEVELOPMENT 131
TABLE 151 ALLERGY THERAPEUTICS : KEY DEVELOPMENT 133
TABLE 152 CIRCASSIA : KEY DEVELOPMENT 136
TABLE 153 DBV TECHNOLOGIES: KEY DEVELOPMENT 139
TABLE 154 STALLERGENES GREER: KEY DEVELOPMENT 142
TABLE 155 MERCK KGAA: KEY DEVELOPMENT 145
TABLE 156 HAL ALLERGY GROUP: KEY DEVELOPMENT 146